What Is A TGA GMP Licence? Requirements For Australian Manufacturers

TGA GMP Licence Licence required for Australian manufacturers performing covered manufacturing steps for therapeutic goods, subject to applicable exemptions.

The TGA GMP Licence is the formal authorisation issued under Australia's regulatory framework that permits a manufacturer to perform specified manufacturing steps for therapeutic goods. It ties legal responsibility for compliance with Good Manufacturing Practice (GMP) to a physical site and defined activities, and it is enforced through inspection, reporting requirements and, where necessary, corrective action or licence sanctions.

Why The Licence Exists

The licence protects public health by ensuring therapeutic goods are consistently produced and controlled to quality standards appropriate for their intended use. Regulators use site-based licences to focus oversight on the places where contamination, mislabelling, cross-contamination and quality system failures can originate. For manufacturers, the licence clarifies obligations, creates a predictable inspection cycle and enables supply into the Australian market.

Who Needs A Licence

Not every business that handles therapeutic goods requires a TGA GMP Licence. The licence applies to Australian manufacturing sites that perform covered manufacturing steps — examples include chemical synthesis of active substances, aseptic filling, batch release activities, and repackaging where those steps affect product quality. Importers, wholesalers or logistics-only handlers who do not perform these covered activities generally are not licenced manufacturers, though they remain subject to other regulatory controls.

How The Licence Is Granted

Licensing starts with an application to the regulator that demonstrates the site meets GMP principles. Typical steps in the process are:

• Documentation: Submit quality manuals, standard operating procedures (SOPs), validation records and organisational charts showing qualified personnel.
• Inspection: The regulator conducts an on-site GMP inspection to verify facilities, equipment, processes and quality systems.
• Corrective Actions: If deficiencies are found, the applicant must provide corrective and preventive action (CAPA) plans and completion evidence.
• Issuance: Once satisfied, the regulator issues a licence that lists permitted activities, conditions and the licence holder’s responsibilities.

What The Licence Typically Covers

Licences are site-specific and activity-specific. A typical licence details:

• Site Address: Physical location authorised to manufacture.
• Permitted Activities: Specific manufacturing steps (e.g., formulation, sterilising, aseptic filling, labelling).
• Product Types: Categories of therapeutic goods allowed under the licence.
• Conditions: Any special conditions, reporting obligations or limits on production.

How It Differs From Other Certifications

The TGA GMP Licence is a legal authorisation, whereas many GMP certificates can be voluntary or issued by other regulators for export. A licence integrates into Australian law and is tied to inspection and enforcement powers; certificates from overseas inspectors (even to the same GMP standards) may not substitute for a local licence when Australian law requires one.

Common Exemptions And Edge Cases

Some activities are explicitly exempt or fall outside the licence requirement, depending on product type and risk. Examples include low-risk repackaging that doesn't affect product integrity, or certain analytical testing where no manufacturing step occurs. Businesses must confirm exemptions with the regulator because misclassification carries compliance risk and potential enforcement.

Practical Example

A contract manufacturer operating an aseptic filling line for sterile injectable medicines must hold a GMP licence for that site and activity. The licence application would include cleanroom qualification, environmental monitoring data, staff training records for aseptic procedures, and validation of sterilisation processes. After inspection and satisfactory CAPA, the site receives a licence listing aseptic filling of injectables as a permitted activity.

Tips For Applicants

• Start Early: Document control, validation and training programmes take months to prepare.
• Use Risk-Based Priorities: Focus on critical areas that affect product sterility, potency or safety first.
• Engage Qualified Staff: Ensure your quality unit and responsible personnel meet regulatory expectations.
• Be Transparent: Present inspection-ready records and disclose CAPA plans promptly when needed.

In short, the TGA GMP Licence is the site-level authorisation Australian manufacturers need when performing covered manufacturing steps for therapeutic goods. It formalises GMP obligations, channels regulatory oversight to the physical place of manufacture and requires documented quality systems, inspection readiness and adherence to conditions specified on the licence.